vorinostat has been researched along with Hypesthesia in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Hypesthesia: Absent or reduced sensitivity to cutaneous stimulation.
Excerpt | Relevance | Reference |
---|---|---|
"Hypoesthesia is a clinical feature of neuropathic pain." | 1.39 | HDAC inhibitors restore C-fibre sensitivity in experimental neuropathic pain model. ( Araki, K; Matsushita, Y; Mukae, T; Omotuyi, Oi; Ueda, H, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsushita, Y | 1 |
Araki, K | 1 |
Omotuyi, Oi | 1 |
Mukae, T | 1 |
Ueda, H | 1 |
1 other study available for vorinostat and Hypesthesia
Article | Year |
---|---|
HDAC inhibitors restore C-fibre sensitivity in experimental neuropathic pain model.
Topics: Acetylation; Analgesics; Animals; Chromatin Assembly and Disassembly; Disease Models, Animal; Epigen | 2013 |